Mitchell L. Krassan
2016
In 2016, Mitchell L. Krassan earned a total compensation of $465.6K as Executive Vice President and Chief Strategy Officer at TherapeuticsMD, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Salary | $300,000 |
| Other | $15,608 |
| Total | $465,608 |
Krassan received $300K in salary, accounting for 64% of the total pay in 2016.
Krassan also received $150K in non-equity incentive plan and $15.6K in other compensation.
Rankings
In 2016, Mitchell L. Krassan's compensation ranked 11,422nd out of 14,075 executives tracked by ExecPay. In other words, Krassan earned more than 18.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,422 out of 14,075 | 19th |
Division Manufacturing | 4,451 out of 5,489 | 19th |
Major group Chemicals And Allied Products | 1,595 out of 1,895 | 16th |
Industry group Drugs | 1,290 out of 1,538 | 16th |
Industry Pharmaceutical Preparations | 1,004 out of 1,176 | 15th |
Source: SEC filing on April 25, 2017.
Krassan's colleagues
We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2016.